Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Deliv
Autors principals: Pranatharthiharan, Sandhya, Patel, Mitesh D., Malshe, Vinod C., Pujari, Vaishali, Gorakshakar, Ajit, Madkaikar, Manisha, Ghosh, Kanjaksha, Devarajan, Padma V.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244555/
https://ncbi.nlm.nih.gov/pubmed/28155331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2016.1225856
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars